Trial intelligence / Profile preview

Phase III trial of group A and C meningococcal polysaccharide vaccine in healthy children, with earlier safety assessment cohorts

CTR20201831Phase 3Active

Sponsor
Institute of Medical Biology Chinese Academy of Medical Sciences
Start
Sep 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal polysaccharide vaccine, groups A and C in meningococcal meningitis, sponsored by Institute of Medical Biology Chinese Academy of Medical Sciences. Started Sep 2020; status: active.

02

Drugs

meningococcal polysaccharide vaccine, groups A and C
03

Conditions

meningococcal meningitis

Beyond the preview

Go deeper on CTR20201831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20201831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call